Persistent depletion of striatal dopamine in mice by 1-Methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine (MTTP)
- 15 January 1986
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (2) , 143-144
- https://doi.org/10.1016/0006-2952(86)90506-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- VI. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: Relationships between monoamine oxidase, MPTP metabolism and neurotoxicityLife Sciences, 1985
- The importance of the ‘4–5’ double bond for neurotoxicity in primates of the pyridine derivative MPTPNeuroscience Letters, 1984
- Effect of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) on monoamine neurotransmitters in mouse brain & heartLife Sciences, 1984
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Reduction of dopamine uptake and cocaine binding in mouse striatum by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridineEuropean Journal of Pharmacology, 1984
- Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkeyBrain Research, 1984
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Influence of chronic pentobarbital or morphine treatment on the incorporation of 32Pi and [3H]choline into rat synaptic plasma membranesBiochemical Pharmacology, 1977